{"entity":{"type":"insider","cik":"0001533340","url":"/insider/0001533340","json_url":"/insider/0001533340.json","name":"Baltic Charles V. III","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":23,"n_filings":13,"first":"2012-07-09","last":"2023-03-01","span_basis":"filed_date"},"name_variants":[{"name":"Baltic Charles V. III","source":"filing","n_filings":13,"first_seen":"2012-07-09","last_seen":"2023-03-01"}],"transactions":[{"id":8722946,"accession":"0001209191-23-014244","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-014244","line_url":"/filing/0001209191-23-014244#line-1","is_derivative":false,"issuer_cik":"0001262104","issuer_name":"MEI Pharma, Inc.","issuer_ticker":"MEIP","issuer_name_source":null,"issuer_url":"/issuer/0001262104","owner_cik":"0001533340","owner_name":"Baltic Charles V. III","owner_display_name":"Baltic Charles V. III","owner_url":"/insider/0001533340","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":81500.0,"shares_display":"81,500","price_per_share":0.225,"price_display":"0.22","price_state":"stated","total_value":18337.5,"total_display":"18,337.50","total_whole":"18,338","shares_owned_after":105750.0,"shares_owned_after_display":"105,750","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-28","filed_date":"2023-03-01","scope":"insider"},{"id":4768859,"accession":"0000899243-17-027566","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-17-027566","line_url":"/filing/0000899243-17-027566#line-2","is_derivative":false,"issuer_cik":"0001262104","issuer_name":"MEI Pharma, Inc.","issuer_ticker":"MEIP","issuer_name_source":null,"issuer_url":"/issuer/0001262104","owner_cik":"0001533340","owner_name":"Baltic Charles V. III","owner_display_name":"Baltic Charles V. III","owner_url":"/insider/0001533340","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.00000002","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11000.0,"shares_display":"11,000","price_per_share":2.2065,"price_display":"2.21","price_state":"stated","total_value":24271.5,"total_display":"24,271.50","total_whole":"24,272","shares_owned_after":13250.0,"shares_owned_after_display":"13,250","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-27","filed_date":"2017-11-29","scope":"insider"},{"id":4768852,"accession":"0000899243-17-027566","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-17-027566","line_url":"/filing/0000899243-17-027566#line-1","is_derivative":false,"issuer_cik":"0001262104","issuer_name":"MEI Pharma, Inc.","issuer_ticker":"MEIP","issuer_name_source":null,"issuer_url":"/issuer/0001262104","owner_cik":"0001533340","owner_name":"Baltic Charles V. III","owner_display_name":"Baltic Charles V. III","owner_url":"/insider/0001533340","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.00000002","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":11000.0,"shares_display":"11,000","price_per_share":2.2546,"price_display":"2.25","price_state":"stated","total_value":24800.6,"total_display":"24,800.60","total_whole":"24,801","shares_owned_after":24250.0,"shares_owned_after_display":"24,250","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-27","filed_date":"2017-11-29","scope":"insider"},{"id":8593176,"accession":"0001209191-15-006102","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-006102","line_url":"/filing/0001209191-15-006102#line-1","is_derivative":false,"issuer_cik":"0001262104","issuer_name":"MEI Pharma, Inc.","issuer_ticker":"MEIP","issuer_name_source":null,"issuer_url":"/issuer/0001262104","owner_cik":"0001533340","owner_name":"Baltic Charles V. III","owner_display_name":"Baltic Charles V. III","owner_url":"/insider/0001533340","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.00000002","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":3.81,"price_display":"3.81","price_state":"stated","total_value":19050.0,"total_display":"19,050.00","total_whole":"19,050","shares_owned_after":24250.0,"shares_owned_after_display":"24,250","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-21","filed_date":"2015-01-23","scope":"insider"},{"id":8058524,"accession":"0001209191-15-000168","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-000168","line_url":"/filing/0001209191-15-000168","is_derivative":false,"issuer_cik":"0001262104","issuer_name":"MEI Pharma, Inc.","issuer_ticker":"MEIP","issuer_name_source":null,"issuer_url":"/issuer/0001262104","owner_cik":"0001533340","owner_name":"Baltic Charles V. III","owner_display_name":"Baltic Charles V. III","owner_url":"/insider/0001533340","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.00000002","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":4.27,"price_display":"4.27","price_state":"stated","total_value":12810.0,"total_display":"12,810.00","total_whole":"12,810","shares_owned_after":19250.0,"shares_owned_after_display":"19,250","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-31","filed_date":"2015-01-02","scope":"insider","n_lines":2},{"id":6798229,"accession":"0001209191-14-044949","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-044949","line_url":"/filing/0001209191-14-044949","is_derivative":false,"issuer_cik":"0001262104","issuer_name":"MEI Pharma, Inc.","issuer_ticker":"MEIP","issuer_name_source":null,"issuer_url":"/issuer/0001262104","owner_cik":"0001533340","owner_name":"Baltic Charles V. III","owner_display_name":"Baltic Charles V. III","owner_url":"/insider/0001533340","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.00000002","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":6.558,"price_display":"6.56","price_state":"stated","total_value":13116.0,"total_display":"13,116.00","total_whole":"13,116","shares_owned_after":17750.0,"shares_owned_after_display":"17,750","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-06-30","filed_date":"2014-07-02","scope":"insider","n_lines":2},{"id":5270267,"accession":"0001209191-13-041556","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-13-041556","line_url":"/filing/0001209191-13-041556","is_derivative":false,"issuer_cik":"0001262104","issuer_name":"MEI Pharma, Inc.","issuer_ticker":"MEIP","issuer_name_source":null,"issuer_url":"/issuer/0001262104","owner_cik":"0001533340","owner_name":"Baltic Charles V. III","owner_display_name":"Baltic Charles V. III","owner_url":"/insider/0001533340","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.00000002 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2600.0,"shares_display":"2,600","price_per_share":6.82,"price_display":"6.82","price_state":"stated","total_value":17732.0,"total_display":"17,732.00","total_whole":"17,732","shares_owned_after":16700.0,"shares_owned_after_display":"16,700","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-08-16","filed_date":"2013-08-20","scope":"insider","n_lines":2},{"id":9268725,"accession":"0001209191-13-041515","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-13-041515","line_url":"/filing/0001209191-13-041515","is_derivative":false,"issuer_cik":"0001262104","issuer_name":"MEI Pharma, Inc.","issuer_ticker":"MEIP","issuer_name_source":null,"issuer_url":"/issuer/0001262104","owner_cik":"0001533340","owner_name":"Baltic Charles V. III","owner_display_name":"Baltic Charles V. III","owner_url":"/insider/0001533340","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.00000002 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10200.0,"shares_display":"10,200","price_per_share":6.042941176470588,"price_display":"6.04","price_state":"stated","total_value":61638.0,"total_display":"61,638.00","total_whole":"61,638","shares_owned_after":15300.0,"shares_owned_after_display":"15,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-01-25","filed_date":"2013-08-20","scope":"insider","n_lines":3},{"id":5265497,"accession":"0001209191-13-004812","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-13-004812","line_url":"/filing/0001209191-13-004812","is_derivative":false,"issuer_cik":"0001262104","issuer_name":"MEI Pharma, Inc.","issuer_ticker":"MEIP","issuer_name_source":null,"issuer_url":"/issuer/0001262104","owner_cik":"0001533340","owner_name":"Baltic Charles V. III","owner_display_name":"Baltic Charles V. III","owner_url":"/insider/0001533340","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.00000002 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10200.0,"shares_display":"10,200","price_per_share":6.042941176470588,"price_display":"6.04","price_state":"stated","total_value":61638.0,"total_display":"61,638.00","total_whole":"61,638","shares_owned_after":17000.0,"shares_owned_after_display":"17,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-01-25","filed_date":"2013-01-29","scope":"insider","n_lines":3},{"id":9268726,"accession":"0001209191-13-041516","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-13-041516","line_url":"/filing/0001209191-13-041516#line-1","is_derivative":false,"issuer_cik":"0001262104","issuer_name":"MEI Pharma, Inc.","issuer_ticker":"MEIP","issuer_name_source":null,"issuer_url":"/issuer/0001262104","owner_cik":"0001533340","owner_name":"Baltic Charles V. III","owner_display_name":"Baltic Charles V. III","owner_url":"/insider/0001533340","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.00000002 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":800.0,"shares_display":"800","price_per_share":6.25,"price_display":"6.25","price_state":"stated","total_value":5000.0,"total_display":"5,000.00","total_whole":"5,000","shares_owned_after":5100.0,"shares_owned_after_display":"5,100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-01-24","filed_date":"2013-08-20","scope":"insider"},{"id":5072211,"accession":"0001209191-13-004571","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-13-004571","line_url":"/filing/0001209191-13-004571#line-1","is_derivative":false,"issuer_cik":"0001262104","issuer_name":"MEI Pharma, Inc.","issuer_ticker":"MEIP","issuer_name_source":null,"issuer_url":"/issuer/0001262104","owner_cik":"0001533340","owner_name":"Baltic Charles V. III","owner_display_name":"Baltic Charles V. III","owner_url":"/insider/0001533340","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.00000002 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":800.0,"shares_display":"800","price_per_share":6.25,"price_display":"6.25","price_state":"stated","total_value":5000.0,"total_display":"5,000.00","total_whole":"5,000","shares_owned_after":6800.0,"shares_owned_after_display":"6,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-01-24","filed_date":"2013-01-28","scope":"insider"},{"id":9268728,"accession":"0001209191-13-041518","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-13-041518","line_url":"/filing/0001209191-13-041518","is_derivative":false,"issuer_cik":"0001262104","issuer_name":"MEI Pharma, Inc.","issuer_ticker":"MEIP","issuer_name_source":null,"issuer_url":"/issuer/0001262104","owner_cik":"0001533340","owner_name":"Baltic Charles V. III","owner_display_name":"Baltic Charles V. III","owner_url":"/insider/0001533340","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.00000002 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3500.0,"shares_display":"3,500","price_per_share":7.17792,"price_display":"7.18","price_state":"stated","total_value":25122.72,"total_display":"25,122.72","total_whole":"25,123","shares_owned_after":4300.0,"shares_owned_after_display":"4,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-12-21","filed_date":"2013-08-20","scope":"insider","n_lines":2},{"id":2214574,"accession":"0001209191-12-059178","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-12-059178","line_url":"/filing/0001209191-12-059178","is_derivative":false,"issuer_cik":"0001262104","issuer_name":"MEI Pharma, Inc.","issuer_ticker":"MEIP","issuer_name_source":null,"issuer_url":"/issuer/0001262104","owner_cik":"0001533340","owner_name":"Baltic Charles V. III","owner_display_name":"Baltic Charles V. III","owner_url":"/insider/0001533340","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.00000002 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3500.0,"shares_display":"3,500","price_per_share":7.17792,"price_display":"7.18","price_state":"stated","total_value":25122.72,"total_display":"25,122.72","total_whole":"25,123","shares_owned_after":4300.0,"shares_owned_after_display":"4,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-12-21","filed_date":"2012-12-26","scope":"insider","n_lines":2},{"id":3164129,"accession":"0001181431-12-040147","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-12-040147","line_url":"/filing/0001181431-12-040147#line-1","is_derivative":false,"issuer_cik":"0001262104","issuer_name":"MEI Pharma, Inc.","issuer_ticker":"MEIP","issuer_name_source":null,"issuer_url":"/issuer/0001262104","owner_cik":"0001533340","owner_name":"Baltic Charles V. III","owner_display_name":"Baltic Charles V. III","owner_url":"/insider/0001533340","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock, par value $0.00000002 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":0.4287,"price_display":"0.43","price_state":"stated","total_value":6430.5,"total_display":"6,430.50","total_whole":"6,431","shares_owned_after":15000.0,"shares_owned_after_display":"15,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-07-05","filed_date":"2012-07-09","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":23,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":22,"open_market":true},{"code":"S","label":"Open-market sale","n":1,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":23},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001262104","name":"MEI Pharma, Inc.","url":"/issuer/0001262104","role":"Director","n_filings":13,"first_seen":"2012-07-09","last_seen":"2023-03-01"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001533340","retrieved_at":"2026-08-25T23:22:32+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}